Luca Giovanella1, Murat Tuncel2, Atena Aghaee3

  • 1Department of Nuclear Medicine, Gruppo Ospedaliero Moncucco, Lugano, Switzerland; Clinic for Nuclear Medicine, University Hospital Zürich, Zürich, Switzerland.

PubMed
概括

分子成像通过整合分子生物标志物和治疗疗法来完善甲状腺癌的管理,以提供个性化的治疗. 这种方法增强了风险分层,并指导各种类型的甲状腺癌的治疗,包括差异化,差异化和髓性甲状腺癌.